Dose Comparison of Misoprostol for Cervix Ripening Before Operative Hysteroscopy.
Status:
Completed
Trial end date:
2020-09-12
Target enrollment:
Participant gender:
Summary
The medication misoprostol is used to facilitate the entry into the uterus of hysteroscopy
surgery equipment and this research aims to compare the results of the use of this drug in
two different doses trying to find the optimal one.
To perform this work we will use the misoprostol and will perform a questionnaire that will
be asked during hospitalization, before, during and the 12hours after the surgery.
The patients who meet the inclusion criteria after signing the Informed Consent Form will be
allocated into two groups getting misoprostol 200mcg or misoprostol 800mcg.
Phase:
Phase 3
Details
Lead Sponsor:
Professor Fernando Figueira Integral Medicine Institute